Insights from 2024 SGO Annual Meeting
Video Player is loading.
10 seconds
Playback speed
SGO 2024 Insights: "Platinum-Free Interval & Response to Platinum Retreatment or Lenvatinib/Pembro in Patients With Recurrent Endometrial Cancer"
By
Insights from 2024 SGO Annual Meeting
FEATURING
Paulina Haight
By
Insights from 2024 SGO Annual Meeting
FEATURING
Paulina Haight
Comments 1
Login to view comments.
Click here to Login
